GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Vendor] QST order #6 — Denmark, 5 days, no drama, receipts inside — 14 comments in the full submission. View in context.
58
c/trialwatch·submitted 1 months ago by u/yusuf_ramos

[Vendor] QST order #6 — Denmark, 5 days, no drama, receipts inside

Discussionbranch of 6 comments

Trying to settle this properly because the thread from last year went in circles. The claim: FLOW matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 9 months without either producing anything. What would actually settle it is 33 people measuring the same thing…

Read the full submission and all 14 comments →

This branch

6 comments, started 1 months ago
u/customs_seizure_sid3 points·1 months ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
u/milos_vanhecke1 point·1 months ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/hazard_ratio_halstats1 point·1 months ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/yusuf_ramos1 point·1 months ago

the discontinuation arms are the interesting part, not the endpoint endpoints

replysharereportpermalink
u/nils_tulloch1 point·1 months ago

Yeah, absolute numbers matter more than the press release.

Yes, exactly this, and it is the bit that took me 65 weeks to accept.

replysharereportpermalink
u/week_four_wall1 point·1 months ago

Yeah, absolute numbers matter more than the press release.

Adding to this: TRIUMPH is doing more work than the comment implies.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →